Dr. Masuo Ohno is a research scientist at Nathan Kline Institute and also serves as associate professor, Department of Psychiatry at NYU Langone Medical Center. He has previously held faculty positions at the Physiology Department of Northwestern University's Feinberg School of Medicine, and earned his Ph.D. from Kyushu University in Japan. Ohno's laboratory focuses on the Alzheimer's beta-secretase enzyme called BACE1, which initiates the production of neurotoxic beta-amyloid from its parent molecule APP. His research team applies multidisciplinary analyses, ranging from molecular to behavioral levels, to various genetically engineered mouse models, aimed at the development of disease-modifying therapeutic interventions to treat Alzheimer's disease and memory deficits.
Masuo Ohno, PhD
First published on: June 11, 2015
Last modified on: November 24, 2024